Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism.
Shen J, Huang J, Huang Y, Chen Y, Li J, Luo P, Zhang Q, Qiu Y, Wang L, Jiang H, Ma S, Chen X.
Shen J, et al. Among authors: huang j, huang y.
Ann Transl Med. 2022 Dec;10(24):1337. doi: 10.21037/atm-22-5438.
Ann Transl Med. 2022.
PMID: 36660682
Free PMC article.